Phornnaphat is a licensed pharmacist with a diverse academic background, holding a bachelor\'s degree in pharmacy from Silpakorn University and a master’s degree in molecular biology from Nagoya University (MEXT Scholarship). With this interdisciplinary training, she specializes in applying data and evidence to inform health policy.Her research foc

Chotika Suwanpanich is a researcher at the Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Thailand. She holds a Doctor of Pharmacy degree from Silpakorn University and has knowledge and experience in health economics, economic evaluations, and impact assessments of health interventions.Chotika has worked o

Parntip Juntama is a Researcher at HITAP specializing in Health Technology Assessment (HTA) and Health Economics. Her work focuses on policy-related research that provides evidence to support healthcare policy decisions in Thailand.Research Focus:Parntip conducts research on various health policy topics to inform national public health strategies.

Jarawee Sukmanee is a researcher at the Health Intervention and Technology Assessment Program Foundation (HITAP). With a background as a medical doctor and epidemiologist, she applies advanced analytical techniques to evaluate the cost-effectiveness of health interventions. She plays a key role in generating evidence to support national policy deci

Pritaporn Kingkaew has been a researcher at HITAP since 2007. She graduated from a joint programme between Srinakharinwirot University, Thailand and the University of Nottingham, UK in 2007 with a Bachelor’s degree in Pharmacy. In 2009, she was awarded the HITAP scholarship to pursue a Master’s degree in Health Economics from the University of York

Yot Teerawattananon is a Assistant Secretary General of the Foundation & Senior Researcher of the Health Intervention and Technology Assessment Program (HITAP), which is a semi-autonomous research institute of Thailand’s Ministry of Public Health. The works of HITAP have been used to inform policy decisions regarding the adoption of medicines,

Epidemiological modelling is an important tool to help public health planners understand potential disease outcomes in the population. The recent visibility of models and their perceived influence in the decision-making processes surrounding the response to the COVID-19 pandemic has led to a great d

Cost-effectiveness and availability of alternative treatment options play a crucial role in the listing of new medicines in South Korea. However, high-cost medicines with no alternative treatment options, particularly those for treating cancer and rare diseases, were not reimbursed under the traditi

A five-day workshop held in Jakarta at the end of October 2015 reviewed and finalized two health technology assessment (HTA) studies in Indonesia. The studies, commissioned by Indonesia’s HTA Committee, were conducted by its Persons in Charge (PICs) in collaboration with Thailand’s Health Inte

With Universal Health Coverage (UHC) high on the global health agenda, governments of many low- and middle-income countries (LMICs) have pledged to increase health investments in the scale-up of essential health services to meet the needs of their people. This has led to the recognition of hea